What is the expected revenue recognition for the 1.2 gigahertz NMR system in 2020
 the corporate average obviously.
So could you give us a view of the parts of businesses where you're getting more traction? And what should continue to work here in the second half despite the comments you made about China and a couple other geographies? Just help us understand what you continue to accelerate in the Project Accelerate or where else that can help.
Frank Laukien -- President and Chief Executive Officer
Yes. I mean, not very much change, Puneet, from what we discussed in New York. So also, high field structural biology, we're optimistic about that. That's progressing, and we expect that to hopefully continue to ramp up in the next year.
Microbiology is doing really quite well, so that continues to be in a good trajectory. Proteomics or omics in general, we're seeing, you know, early, early, early growth there. It's not enormous for us yet, but it's becoming -- as we had predicted at the beginning of the year, it's beginning to kick in to where it is, beginning to positively move the needle. And our pharma business, our pharma business has continued to grow in terms of revenue very significantly.
That's also worked well for us last year, if you recall. So on the negative side, semiconductor isn't recovering. It's not recovering in the second half of this year as some might have hoped earlier in the year. We actually didn't bet on that anyway.
And so now, it's predicted. So I'd say those -- all the drivers are more or less along the lines of what we discussed in New York at the investor day. So a lot of good secular trends that we've positioned now, a lot of good product innovation. So with that, even with a potentially weaker or likely weakening China and weakening industrial, I think we will continue to do quite well.
Puneet Souda -- SVB Leerink -- Analyst
OK. Thanks. And then on the NMR front, could you tell us where the 1 gigahertz, was it North America, Europe and other geography? And then one of those is in the revenues, but [Inaudible] are suggesting there is another gigahertz in the field at the customer lab already installed and operating. So just trying to understand sort of what's keeping that out of the guidance that's still in the second half here? And then what's maybe the caution there? And then when should we expect the 1.2 gigahertz within the factory to be shipped out to the customer? I assume that's a 2020 event.
Thank you.
Frank Laukien -- President and Chief Executive Officer
Right. Working backwards then. 1.2 gigahertz shipment from factories. We have not set a target date for that.
I would tend to agree with you that's more likely to be -- I mean, it's certainly not a 2019 revenue event. That's impossible. And when exactly we ship that, perhaps this winter. But that could obviously also go into 2020.
And then typically, it takes more months to install those. So there's more uncertainty around that. Then the 1.0 gigahertz on which we had revenue recognition was in Israel, and we are, as you know, we've shipped another 1.0 gigahertz. We're not guiding one way or another of whether that's going to be in our revenue in the second half of the year.
And we're not reluctant about that. It is just something that we -- we can't really call the quarter when these things happen. And maybe the one thing, if I may add to that, don't think of those generally as something that's on top of everything else sort of as a bonus in the quarter. We look at our acquired growth.
We look at our best growth. We look of course where there's a gigahertz in the mix or not in any given quarter. And then you know, those are all the pieces along that we've used for planning our quarters to try to deliver and beat the quarters if we can. And of course, with a full focus on the annual guidance to which we are committed.
So in short, we're not guiding on this one way or the other. It is possible that a second one could be in revenue, but we're non-committal about it simply because it's not that easy to predict. It also doesn't matter that much. It's not something that we couldn't come on top of everything.
So whatever w
 the corporate average obviously.
So could you give us a view of the parts of businesses where you're getting more traction? And what should continue to work here in the second half despite the comments you made about China and a couple other geographies? Just help us understand what you continue to accelerate in the Project Accelerate or where else that can help.
Frank Laukien -- President and Chief Executive Officer
Yes. I mean, not very much change, Puneet, from what we discussed in New York. So also, high field structural biology, we're optimistic about that. That's progressing, and we expect that to hopefully continue to ramp up in the next year.
Microbiology is doing really quite well, so that continues to be in a good trajectory. Proteomics or omics in general, we're seeing, you know, early, early, early growth there. It's not enormous for us yet, but it's becoming -- as we had predicted at the beginning of the year, it's beginning to kick in to where it is, beginning to positively move the needle. And our pharma business, our pharma business has continued to grow in terms of revenue very significantly.
That's also worked well for us last year, if you recall. So on the negative side, semiconductor isn't recovering. It's not recovering in the second half of this year as some might have hoped earlier in the year. We actually didn't bet on that anyway.
And so now, it's predicted. So I'd say those -- all the drivers are more or less along the lines of what we discussed in New York at the investor day. So a lot of good secular trends that we've positioned now, a lot of good product innovation. So with that, even with a potentially weaker or likely weakening China and weakening industrial, I think we will continue to do quite well.
Puneet Souda -- SVB Leerink -- Analyst
 OK. Thanks. And then on the NMR front, could you tell us where the 1 gigahertz, was it North America, Europe and other geography? And then one of those is in the revenues, but [Inaudible] are suggesting there is another gigahertz in the field at the customer lab already installed and operating. So just trying to understand sort of what's keeping that out of the guidance that's still in the second half here? And then what's maybe the caution there? And then when should we expect the 1.2 gigahertz within the factory to be shipped out to the customer? I assume that's a 2020 event.
Thank you.
Frank Laukien -- President and Chief Executive Officer
Right. Working backwards then. 1.2 gigahertz shipment from factories. We have not set a target date for that.
I would tend to agree with you that's more likely to be -- I mean, it's certainly not a 2019 revenue event. That's impossible. And when exactly we ship that, perhaps this winter. But that could obviously also go into 2020.
And then typically, it takes more months to install those. So there's more uncertainty around that. Then the 1.0 gigahertz on which we had revenue recognition was in Israel, and we are, as you know, we've shipped another 1.0 gigahertz. We're not guiding one way or another of whether that's going to be in our revenue in the second half of the year.
And we're not reluctant about that. It is just something that we -- we can't really call the quarter when these things happen. And maybe the one thing, if I may add to that, don't think of those generally as something that's on top of everything else sort of as a bonus in the quarter. We look at our acquired growth.
We look at our best growth. We look of course where there's a gigahertz in the mix or not in any given quarter. And then you know, those are all the pieces along that we've used for planning our quarters to try to deliver and beat the quarters if we can. And of course, with a full focus on the annual guidance to which we are committed.
 So in short, we're not guiding on this one way or the other. It is possible that a second one could be in revenue, but we're non-committal about it simply because it's not that easy to predict. It also doesn't matter that much. It's not something that we couldn't come on top of everything.
So whatever w